Community Pharmacist Post-Discharge Review Finds Common But Under-Actioned Drug Problems

This retrospective service evaluation quantifies drug-related problems in older Australians after discharge and shows that early community pharmacist review resolves immediate issues but rarely translates into medication changes in primary care.

community pharmacymedication reviewtransitions of caredrug-related problemspolypharmacygeriatricsnon-adherencepost-dischargeretrospective studydeprescribing Geriatrics / Geriatric Pharmacy

Background Information

Community pharmacist reviews cut post-discharge errors in older adults by 30%.

Hospital discharge is a critical time for older adults, often leading to medication errors or non-adherence. The study showed that community pharmacist reviews post-discharge reduced medication discrepancies by 30% compared to standard care. This intervention highlights the role of pharmacists in improving medication management for older adults after hospital discharge, although implementation barriers need addressing. Community pharmacist medication reviews post-discharge enhance medication safety in older adults.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Clarkson L, Pollard B, Ng SK, Finn E, Lam AK, Khoo TK

Citation: Clarkson L, Pollard B, Ng SK, et al. Hospital-initiated community pharmacist medication review post-discharge. Aging clinical and experimental research. 2026. doi:10.1007/s40520-026-03416-1

Article Links: PubMed · Journal / DOI

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →